NCV

Virtus Convertible & Income Fund Announces Quarterly Distribution: 5.625% Series A Cumulative Preferred Shares

Retrieved on: 
星期五, 三月 1, 2024
Banking, Professional Services, Finance, NCV, Fitch Ratings

Virtus Convertible & Income Fund (NYSE: NCV) announced today that it has declared a $0.3515625 per share cash distribution payable on March 29, 2024 to Series A cumulative preferred shareholders of record on March 11, 2024.

Key Points: 
  • Virtus Convertible & Income Fund (NYSE: NCV) announced today that it has declared a $0.3515625 per share cash distribution payable on March 29, 2024 to Series A cumulative preferred shareholders of record on March 11, 2024.
  • The Series A Cumulative Preferred Shares, which trade on the New York Stock Exchange under the symbol NCV PR A, are rated “A” by Fitch Ratings and have an annual dividend rate of $1.40625 per share.
  • The 4,000,000 Series A Cumulative Preferred Shares were issued September 20, 2018 at $25.00 per share and pay distributions quarterly.
  • The Series A Cumulative Preferred Shares are now callable at any time at the liquidation value of $25.00 per share plus accrued dividends.

The Inner Circle Acknowledges, Jose A. Matus as a Top Pinnacle Professional

Retrieved on: 
星期一, 二月 19, 2024
NCV, School, ABPN, Veterans Health Administration, Inner circle, Suite, Multimedia, Medical director, Skiing, Seizure, Rehabilitation hospital, American Medical Association, Texas Medical Association, BPN, Electrodiagnostic medicine, Internal medicine, Patient, Medicine, EMG, Psychiatry, Fellow, DSM-IV codes, American Academy

SHERMAN, Texas, Feb. 19, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology.

Key Points: 
  • SHERMAN, Texas, Feb. 19, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology.
  • Dr. Matus earned a medical degree from the School of Medicine at The Universidad de San Carlos de Guatemala in 1982.
  • He finished a Neurology Residency in 1995 at the Loma Linda University Medical Center in Loma Linda, CA.
  • Dr. Matus sees patients for acute neurology care and performs neuro-diagnostic procedures like EMG, NCV EEGs, and Carotid Ultrasounds.

Virtus Convertible & Income Fund Announces Quarterly Distribution: 5.625% Series A Cumulative Preferred Shares

Retrieved on: 
星期五, 十二月 1, 2023
Professional Services, Finance, NYSE, Fitch Ratings, NCV, Life insurance, Cryptocurrency

Virtus Convertible & Income Fund (NYSE: NCV) announced today that it has declared a $0.3515625 per share cash distribution payable on December 29, 2023 to Series A cumulative preferred shareholders of record on December 11, 2023.

Key Points: 
  • Virtus Convertible & Income Fund (NYSE: NCV) announced today that it has declared a $0.3515625 per share cash distribution payable on December 29, 2023 to Series A cumulative preferred shareholders of record on December 11, 2023.
  • The Series A Cumulative Preferred Shares, which trade on the New York Stock Exchange under the symbol NCV PR A, are rated “A” by Fitch Ratings and have an annual dividend rate of $1.40625 per share.
  • The 4,000,000 Series A Cumulative Preferred Shares were issued September 20, 2018 at $25.00 per share and pay distributions quarterly.
  • The Series A Cumulative Preferred Shares are now callable at any time at the liquidation value of $25.00 per share plus accrued dividends.

Enviva Reports 3Q 2023 Results

Retrieved on: 
星期四, 十一月 9, 2023
Forest Products, Energy, Natural Resources, Other Energy, Sale, Biomass, Negotiation, Health, DAP, Public expenditure, EBITDA, Net, GAAP, Wind, Acquisition, Maintenance, Environment, Plant, Webcast, CFO, Vinson & Elkins, Heat, Wood, Metric, NCV, Security (finance), Video game, Pharmaceutical industry, Cryptocurrency, Bank, Renewable energy, Enviva, Bond

Third-quarter 2023 volumes increased by approximately 10% as compared to second-quarter 2023, with volume uplift being driven by production improvements being implemented across Enviva’s plant fleet.

Key Points: 
  • Third-quarter 2023 volumes increased by approximately 10% as compared to second-quarter 2023, with volume uplift being driven by production improvements being implemented across Enviva’s plant fleet.
  • For third-quarter 2023, DAP per MT was $152, down $9 per MT from $161 reported for second-quarter 2023.
  • Additionally, Enviva anticipates that fourth-quarter 2023 results, excluding any impacts from the Q4 2022 Transactions, could potentially be weaker than results for third-quarter 2023, as higher spot prices have not materialized and the Company expects to incur higher sales, general, and administrative expenses associated with the engagement of financial and legal advisors in connection with the comprehensive review described above.
  • Enviva will host a webcast and conference call on Thursday, November 9, 2023 at 8:30 a.m. Eastern Time to discuss third-quarter results and the Company’s operations and outlook.

Rhythmlink Announces New Addition to EMG/NCV Line: The Concentric Needle Family

Retrieved on: 
星期五, 十月 13, 2023
Biotechnology, Health, Neurology, Medical Devices, Multimedia, Critical care, Patient, Marketing, Long-term video-EEG monitoring, ICU, NCV, EMG, Electrode, Physician, International, Medical device

View the full release here: https://www.businesswire.com/news/home/20231011421601/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231011421601/en/
    Rhythmlinks's new Concentric Needle product (Photo: Business Wire)
    The concentric needle is offered in four sizes or gauges, which also vary in needle diameter, length and color, matching currently accepted workflows.
  • The disposable concentric needle pairs with a reusable cable designed specifically to work with Rhythmlink’s needles.
  • The concentric needle family joins other recent product releases, such as Sticky Pad Surface Electrodes formulated for NCV, both with and without a leadwire.
  • Learn more about Rhythmlink’s full line of products at www.Rhythmlink.com and more about the Concentric Needle at www.Rhythmlink.com/Concentric .

ImmunityBio Announces $470 Million Equity and Debt Financing From Founder, Dr. Patrick Soon-Shiong and Nant Entities

Retrieved on: 
星期一, 九月 11, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Infectious Diseases, Clinical Trials, Medicine, Therapy, NCV, Cancer, Bladder cancer, NK, NAnt, BCG, Patrick Soon-Shiong, Physician, Immune system, Security (finance), Pharmaceutical industry, ImmunityBio COVID-19 vaccine

The new $200 million convertible note with Nant Capital has a three-year term and is convertible into shares of ImmunityBio common stock at a conversion price of a fifty percent (50%) premium over the closing market price immediately preceding the date of the note.

Key Points: 
  • The new $200 million convertible note with Nant Capital has a three-year term and is convertible into shares of ImmunityBio common stock at a conversion price of a fifty percent (50%) premium over the closing market price immediately preceding the date of the note.
  • In addition, the financing transactions restructure the Company’s existing debt obligations with the Nant entities, including an extension of the nearest term debt maturities by one year to December 2024.
  • “With this additional financing, we are well positioned to execute on our commercialization plans in anticipation of the approval of N-803 plus BCG in bladder cancer.
  • We recognize the enormity of such a challenge and this investment will enable the scientists and physicians to pursue the goal of potentially curing cancer in our lifetime.”

Virtus Convertible & Income Fund Announces Quarterly Distribution: 5.625% Series A Cumulative Preferred Shares

Retrieved on: 
星期五, 九月 1, 2023
Professional Services, Finance, Fitch Ratings, NCV, NYSE, Airline, Rare-earth element, Life insurance

Virtus Convertible & Income Fund (NYSE: NCV) announced today that it has declared a $0.3515625 per share cash distribution payable on September 29, 2023 to Series A cumulative preferred shareholders of record on September 11, 2023.

Key Points: 
  • Virtus Convertible & Income Fund (NYSE: NCV) announced today that it has declared a $0.3515625 per share cash distribution payable on September 29, 2023 to Series A cumulative preferred shareholders of record on September 11, 2023.
  • The Series A Cumulative Preferred Shares, which trade on the New York Stock Exchange under the symbol NCV PR A, are rated “A” by Fitch Ratings and have an annual dividend rate of $1.40625 per share.
  • The 4,000,000 Series A Cumulative Preferred Shares were issued September 20, 2018 at $25.00 per share and pay distributions quarterly.
  • The Series A Cumulative Preferred Shares will be callable at any time at the liquidation value of $25.00 per share plus accrued dividends from and after the expiration of a five-year non-call period on September 20, 2023.

Enviva Reports 2Q 2023 Results and Provides Progress Update on Cost and Productivity Improvement Initiatives

Retrieved on: 
星期三, 八月 2, 2023
Automotive, Forest Products, Other Energy, Agriculture, Natural Resources, Green Technology, Alternative Vehicles, Fuels, Alternative Energy, Environment, Energy, Sustainability, Carbon, Metric, European Union Emissions Trading System, EPC, EU Council, GAAP, Wood, Forest management, Federation, Acquisition, Investment, Tornado, EU ETS, European, Heat, BECCS, RED, Maintenance, NCV, Language, Organization, Coal, Growth, Biomass, Net, Public policy, Government, Engineering, Natural gas, European Parliament, Webcast, Hand, Enviva, Minister, Wind, Public expenditure, Plant, EBITDA, Bioenergy with carbon capture and storage, Renewable energy, DAP, Security (finance), Video game, Pharmaceutical industry, Engineered wood, Fine chemical, Bond, EU

As a result, Greenwood is on a path to reach its target production level and cost position during fourth-quarter 2023.

Key Points: 
  • As a result, Greenwood is on a path to reach its target production level and cost position during fourth-quarter 2023.
  • Enviva continues to advance cost-reduction and productivity initiatives designed to improve the financial and operating performance of its fully contracted assets.
  • During second-quarter 2023, management was able to reduce DAP cost by approximately $3 per MT as compared to first-quarter 2023, and reduced DAP cost by $9 per MT from first-quarter 2023 to June 2023.
  • Enviva will host a webcast and conference call on Thursday, August 3, 2023 at 10:00 a.m. Eastern Time to discuss second-quarter results and the Company’s outlook.

Virtus Convertible & Income Fund Announces Quarterly Distribution: 5.625% Series A Cumulative Preferred Shares

Retrieved on: 
星期四, 六月 1, 2023
Other Professional Services, Professional Services, Finance, Fitch Ratings, NCV, NYSE, Life insurance, Cryptocurrency

Virtus Convertible & Income Fund (NYSE: NCV) announced today that it has declared a $0.3515625 per share cash distribution payable on June 30, 2023 to Series A cumulative preferred shareholders of record on June 12, 2023.

Key Points: 
  • Virtus Convertible & Income Fund (NYSE: NCV) announced today that it has declared a $0.3515625 per share cash distribution payable on June 30, 2023 to Series A cumulative preferred shareholders of record on June 12, 2023.
  • The Series A Cumulative Preferred Shares, which trade on the New York Stock Exchange under the symbol NCV PR A, are rated “A” by Fitch Ratings and have an annual dividend rate of $1.40625 per share.
  • The 4,000,000 Series A Cumulative Preferred Shares were issued September 20, 2018 at $25.00 per share and pay distributions quarterly.
  • The Series A Cumulative Preferred Shares will be callable at any time at the liquidation value of $25.00 per share plus accrued dividends from and after the expiration of a five-year non-call period on September 20, 2023.

Certain Virtus Closed-End Funds Announce Date of Shareholder Meetings

Retrieved on: 
星期四, 三月 23, 2023
Banking, Professional Services, Finance, EDF, EDI, Interest, Funding, NCV, EDT, Sale, CBH, NCZ, Trustee, Risk, Artificial intelligence, NYSE, NIE, NFJ, Security (finance)

Virtus Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO), Virtus Convertible & Income 2024 Target Term Fund (NYSE: CBH), Virtus Convertible & Income Fund (NYSE: NCV), Virtus Convertible & Income Fund II (NYSE: NCZ), Virtus Diversified Income & Convertible Fund (NYSE: ACV), Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ), Virtus Equity & Convertible Income Fund (NYSE: NIE), and Virtus Stone Harbor Emerging Markets Total Income Fund (NYSE: EDI) have announced that they will hold a virtual joint meeting of shareholders on May 22, 2023 at 1 p.m. EDT.

Key Points: 
  • Virtus Artificial Intelligence & Technology Opportunities Fund (NYSE: AIO), Virtus Convertible & Income 2024 Target Term Fund (NYSE: CBH), Virtus Convertible & Income Fund (NYSE: NCV), Virtus Convertible & Income Fund II (NYSE: NCZ), Virtus Diversified Income & Convertible Fund (NYSE: ACV), Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ), Virtus Equity & Convertible Income Fund (NYSE: NIE), and Virtus Stone Harbor Emerging Markets Total Income Fund (NYSE: EDI) have announced that they will hold a virtual joint meeting of shareholders on May 22, 2023 at 1 p.m. EDT.
  • Virtus Stone Harbor Emerging Markets Income Fund (NYSE: EDF) will hold its virtual meeting of shareholders on May 22, 2023 at 1:30 p.m. EDT.
  • Each fund’s Board of Trustees has fixed the close of business on March 31, 2023 as the record date for the determination of shareholders who will be entitled to receive notice of, and vote at, the meetings.
  • For more information on the Funds, contact Shareholder Services at (866) 270-7788, by email at [email protected] , or through the closed-end funds section of virtus.com .